2021-10-19 19:00:35| Fool.com Headlines
The insurance tech company can't seem to get out of its slump.
2021-10-19 18:49:30| Fool.com Headlines
The young biopharma outfit is set to become part of a major market index, which means a buying spree is on the radar.
2021-10-19 17:56:00| Fool.com Headlines
The company's oral COVID-19 treatment looks like a dud in the mild-to-moderate COVID-19 setting.
2021-10-19 17:50:00| Fool.com Headlines
The company reported earnings results for the third quarter of 2021.
2021-10-19 17:33:12| Fool.com Headlines
Sales and earnings will miss estimates in the third quarter.